NCT06623617

Brief Summary

\*\*Clinical Trial\*\* This clinical trial aims to investigate the clinical therapeutic effects of breathing training on postpartum stress urinary incontinence (PPSUI). Participants will: All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum recovery recommendations, and educational information. Control Group: Participants will receive conventional pelvic floor rehabilitation therapy, which may include one or a combination of the following: magnetic stimulation therapy, electromyographic biofeedback therapy, and manual therapy. The specific treatment methods and frequency will be determined based on individual patient conditions. Intervention Group: In addition to the same pelvic floor rehabilitation therapy as the control group, participants will receive breathing training. Before each session, participants will empty their bladder. The breathing training will be conducted under researcher supervision and guidance, with each session lasting 20 minutes, administered once daily, three times per week for 6 weeks. Participants are encouraged to perform the training in the hospital under researcher supervision. Those unable to attend in-person sessions may conduct home-based training after mastering the technique and must report their training status to researchers afterward. Researchers will monitor weekly training completion and provide timely reminders to ensure adherence. If dizziness or difficulty breathing occurs during training, participants must immediately discontinue the session.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 2, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

March 27, 2026

Status Verified

April 1, 2025

Enrollment Period

1 year

First QC Date

September 28, 2024

Last Update Submit

March 23, 2026

Conditions

Keywords

Postpartum Stress Urinary IncontinenceBreathing training

Outcome Measures

Primary Outcomes (1)

  • Severity of PPSUI

    The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), developed by the International Continence Society (ICS), serves as the standardized assessment tool. This 4-domain questionnaire evaluates: Frequency of urine leakage Volume of leakage Impact on daily life Timing of leakage Severity Grading (based on first 3 domains): Mild: Total score ≤7 Moderate: 7 \< score ≤14 Severe: 14 \< score ≤21

    Before and after 6 weeks of intervention

Secondary Outcomes (6)

  • Pelvic Floor Muscle Strength

    Before and after 6 weeks of intervention

  • Pelvic Floor Surface Electromyography

    Before and after 6 weeks of intervention

  • Transversus Abdominis (TrA) Contraction Rate

    Before and after 6 weeks of intervention

  • Maximum Voluntary Contraction (MVC) of Pelvic Floor Muscles

    Before and after 6 weeks of intervention

  • Diaphragmatic Excursion During Deep Breathing and Coughing

    Before and after 6 weeks of intervention

  • +1 more secondary outcomes

Study Arms (2)

Control group

OTHER

All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum recovery recommendations, and educational information. Participants will receive conventional pelvic floor rehabilitation therapy, which may include one or a combination of the following: magnetic stimulation therapy, electromyographic biofeedback therapy, and manual therapy. The specific treatment methods and frequency will be determined based on individual patient conditions.

Behavioral: control group

Intervention Group:Breathing training group

EXPERIMENTAL

All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum In addition to the same pelvic floor rehabilitation therapy as the control group, participants will receive breathing training. Before each session, participants will empty their bladder. The breathing training will be conducted under researcher supervision and guidance, with each session lasting 20 minutes, administered once daily, three times per week for 6 weeks. Participants are encouraged to perform the training in the hospital under researcher supervision. Those unable to attend in-person sessions may conduct home-based training after mastering the technique and must report their training status to researchers afterward. Researchers will monitor weekly training completion and provide timely reminders to ensure adherence. If dizziness or difficulty breathing occurs during training, participants must immediately discontinue the session.

Behavioral: Breathing trainingBehavioral: control group

Interventions

All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum r In addition to the same pelvic floor rehabilitation therapy as the control group, participants will receive breathing training. Before each session, participants will empty their bladder. The breathing training will be conducted under researcher supervision and guidance, with each session lasting 20 minutes, administered once daily, three times per week for 6 weeks. Participants are encouraged to perform the training in the hospital under researcher supervision. Those unable to attend in-person sessions may conduct home-based training after mastering the technique and must report their training status to researchers afterward. Researchers will monitor weekly training completion and provide timely reminders to ensure adherence. If dizziness or difficulty breathing occurs during training, participants must immediately discontinue the session.

Intervention Group:Breathing training group
control groupBEHAVIORAL

All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum recovery recommendations, and educational information. Participants will receive conventional pelvic floor rehabilitation therapy, which may include one or a combination of the following: magnetic stimulation therapy, electromyographic biofeedback therapy, and manual therapy. The specific treatment methods and frequency will be determined based on individual patient conditions.

Control groupIntervention Group:Breathing training group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: ≥18years
  • weeks to 6 months postpartum
  • Diagnosed with postpartum stress urinary incontinence (PPSUI) by a pelvic floor rehabilitation specialist

You may not qualify if:

  • Diabetes mellitus
  • Body mass index (BMI) \>30 kg/m²
  • Cardiopulmonary or renal dysfunction
  • Neurological disorders
  • Pelvic organ prolapse exceeding stage II
  • History of lumbopelvic surgery
  • Lumbopelvic pain
  • Concurrent treatments that may interfere with study outcomes
  • Professional athletes
  • Current pregnancy
  • Withdrawal Criteria:
  • Failure to complete follow-up assessments
  • Loss of contact with participants
  • Termination Criteria:
  • Immediate discontinuation if participants experience dizziness, chest tightness, palpitations, or dyspnea during training
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shenzhen Hospital of Southern Medical University

Guangzhou, Shenzhen, China

RECRUITING

MeSH Terms

Conditions

Urinary Incontinence, Stress

Interventions

Breathing ExercisesControl Groups

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy ModalitiesEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Wenzhi First Name: (Wenzhi) Middle initial: () Degree: (Professor)

    Shenzhen Hospital of Southern Medical University

    STUDY CHAIR

Central Study Contacts

Jie First Name: (jie) Middle initial: () Degree: (Ph.D. candidate)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

September 28, 2024

First Posted

October 2, 2024

Study Start

May 1, 2025

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

March 27, 2026

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations